“Too optimistic” on vaccine deliveries, the EU wants to beef up its production – Release
The Covid-19 pandemic in Francedossier
Vaccination, re-containment, epidemic assessment, virus mutation … Find the latest information on the health crisis linked to the Covid-19 pandemic.
published on February 10, 2021 at 10:50 a.m.
(updated at 12:23)
Failures. Under fire from criticism, the President of the European Commission Ursula von der Leyen admitted this morning before the European Parliament to have been “too optimistic”Regarding the delivery times of anti-Covid vaccines in the EU. “We underestimated the difficulties of mass production […] We have been overly optimistic, and arguably overconfident about the timely delivery of the doses ordered.”, Admitted the head of the European executive, responsible for negotiating the doses of vaccines for the Twenty-Seven, in front of the MEPs meeting in plenary session in the Brussels hemicycle. To boost the mass production of vaccines in the EU, Ms von der Leyen announced the creation of a “work group”Under the aegis of Internal Market Commissioner Thierry Breton for“identify problems”Relating to the management of production which“involves up to 100 companies”And“solve them”.
Syringes. Japan will launch its vaccination campaign next week, Prime Minister Yoshihide Suga announced, if the Pfizer / BioNTech vaccine is validated by the Ministry of Health at a meeting scheduled for Friday. However, the country faces a shortage of syringes. These must allow the extraction of the six doses of vaccine provided in a vial. Problem: after checking the stocks, the syringes available to the country can only extract five. A logistical dysfunction that could force him to give up the serum for some 12 million people, according to the local press. Less than six months before the start of the Tokyo Olympics postponed last summer to this summer because of the pandemic, the plan for the vaccination campaign has still not been presented.
The chain. The BioNTech laboratory announces the opening of a new factory to produce mRNA, the active ingredient in the anti-Covid vaccine designed with Pfizer. It will be located in Marburg, in the Land of Hesse, Germany, a production site in addition to the main factory based in Puurs, Belgium. Objective: to increase deliveries, says the laboratory. This production, then transferred to “production partnersResponsible for packaging and sterilizing it, must first receive the green light from the European Medicines Agency in February and March, for distribution scheduled for early April. BioNTech plans to produce up to 250 million doses of the vaccine there by June, with the production capacity of this new facility expected to reach 750 million “once fully operational“, According to the laboratory.
Vaccinated culture. Roselyne Bachelot said she was opposed to the idea of making access to cultural places conditional on the presentation of a vaccination passport. “I remain opposed to the vaccine passport which seems to me an attack on our freedoms. The lover of freedoms that I am has a hard time imagining it! If we got therethere, it would be a step back“, Underlined the minister, questioned on France 2. The Minister of Culture also reacted to the reopening by the mayor of Perpignan Louis Aliot of four museums, a decision contrary to “respect for the republican principle“, according to her: “It is all the same curious that the mayor does not respect the laws of the Republic and does not apply the rules to himself».
Grand oral. The President of the European Commission, Ursula von der Leyen, today defends her strategy on vaccines before the European Parliament, meeting in plenary session. Faced with the delays in the deliveries of batches of doses, the management by the European executive of vaccine orders is the subject of many criticisms that cluster around its president. Among them, the lack of transparency of contracts negotiated with pharmaceutical companies. If some MEPs from the Health Committee in the European Parliament had been able to consult certain documents, they were partly crossed out. Another controversy on the agenda of the grand oral: the national authorization mechanism for vaccine exports to third countries.
USA vs. OMS. On the last day of his stay in China, Peter Daszak, one of the World Health Organization (WHO) experts sent to Wuhan to investigate the origin of the virus, questioned the reliability of US intelligence on the pandemic in a tweet. He was reacting to statements by the spokesperson for the US State Department. The international delegation ruled on Tuesday that the hypothesis of a leak of the virus from the laboratory of the Wuhan Institute of Virology was “highly improbable», While this is the preferred avenue for Washington. The findings of the team sent to China did not therefore convince Ned Price, spokesman for American diplomacy. “Rather than jumping to conclusions that can be driven by anything but science, we want to see where the data takes us, where the science takes us, and our conclusions will be based on that.“, did he declare. Notable fact: Peter Daszak is also president of an association based in the United States which has collaborated with this famous institute on certain projects. In Wuhan, families of victims denounce a “Passive investigation” and “Not independent” of the WHO.
*The article has been translated based on the content of Libération by www.liberation.fr. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!